MarketsandMarkets: Global H1N1 2009 Influenza Vaccine Market Worth US$ 7,028 Million By 2011
WILMINGTON, Delaware, October 22 -- A new market research report, 'Global H1N1 2009 Influenza Vaccine', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the global H1N1 2009 Influenza vaccine market over the period 2009-2012. The report studies the major market drivers, restraints, and opportunities for global H1N1 2009 Influenza vaccine market and also evaluates the major pandemic trends with respect to different geographic regions.
Browse in-depth TOC on stem cell market. Early buyers will receive 10% customization of report.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
The global H1N1 2009 Influenza vaccine market is estimated to be $7,028 billion by 2011, growing at a CAGR of 222.4 % from 2009 to 2011. Some of the key players in this market are GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals.
The global H1N1 2009 Influenza vaccine market is growing due to the prevailing pandemic of H1N1 influenza and huge demand from different countries for the vaccines against it. The H1N1 Influenza vaccine market is mainly driven by the increasing awareness of the population, global spread of H1N1 influenza and the initiatives taken by government & other public institutions for immunization of the population against H1N1 influenza. The North America region is the current lucrative market for H1N1 influenza vaccines with other regions also having high infection rate across the population.
Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.
SCOPE AND FORMAT
This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.
Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.
Geography Markets: North America, Europe, Asia-Pacific and ROW
Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.
Analyst Briefings on 27th Oct 2009 The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Opportunity Analysis- H1N1 (Swine Flu) Vaccination Market ( http://www.marketsandmarkets.com/Market-Reports/influenza-vaccines-market-159 .html ) (2009-2012) to be held on 27th Oct 2009
To register your participation, please click here http://www.marketsandmarkets.com/AnalystBriefing/swine-Flu-vaccination-market .asp
(Due to the length of these URLs, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
Contact our representative to sponsor this report
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at http://www.marketsandmarkets.com.
Contact: Ms. Sunita 108, West 13th Street, Wilmington DE, 19801 County of New Castle Tel: +1-888-989-8004 Email: firstname.lastname@example.org
SOURCE Markets and Markets